Medicine and Dentistry
Metastatic Carcinoma
100%
Bone Metastasis
70%
Bone Remodeling
60%
Osteoplasty
60%
Claudin
50%
Macrophage
50%
Bone Marrow Stromal Cell
50%
T Cell
50%
Cellular Infiltration
50%
Macrophage Migration Inhibition
50%
B Cell
50%
Triple Negative Breast Cancer
50%
Neoplasm
50%
Breast Cancer
37%
Cancer Cell
26%
Treatment Response
25%
Cyclophosphamide
25%
Cancer
20%
Hematopoiesis
20%
Cell Proliferation
16%
Pathologic Fracture
16%
Stromal Cell
16%
Nerve Cell Adhesion Molecule
16%
Cell Migration
16%
In Vitro
16%
T-Helper Cell
12%
Tertiary Lymphoid Structure
12%
Breast Tumor
12%
Tumor Immune Microenvironment
12%
Immunotherapy
12%
Immunosuppressive Drug
12%
RNA Sequence
12%
Tumor Model
12%
Immune Response
12%
Overall Survival
12%
Lung Metastasis
12%
Tumor Regression
12%
Low Drug Dose
12%
Cancer Model
12%
Tumor Microenvironment
12%
Protein P53
12%
Tumor Infiltrating Lymphocyte
12%
Imaging Technique
12%
Combination Therapy
12%
Primary Tumor
10%
Bone Development
10%
Homeostasis
10%
Immunomodulation
10%
Immunology and Microbiology
Tumor Cell
75%
Bone Remodeling
62%
Immunosurveillance
50%
Granulocyte
50%
Claudin
50%
B Cell
50%
Immunosuppression
50%
Natural Killer Cell
50%
Tumor-Associated Macrophage
50%
T Cell
50%
Macrophage Migration Inhibition
50%
Osteoprogenitor Cell
50%
Cell Infiltration
50%
Circulating Tumor Cell
41%
Lineage
33%
Cancer Cell
29%
Cyclophosphamide
25%
Immunotherapy
25%
Immunity
25%
Immunosuppressive Drug
25%
Hematopoiesis
25%
Cell Migration
16%
Cell Proliferation
16%
Coculture
16%
Neural Cell Adhesion Molecule
16%
P53
12%
Immunomodulation
12%
Tertiary Lymphoid Structure
12%
Myeloid
12%
RNA Sequence
12%
Bone Development
12%
Tumor Volume
12%
Tumor Immunity
12%
CD86
12%
Syngenic
12%
Low Drug Dose
12%
Hematopoietic Cell
12%
Mouse Model
12%
Knockout Mouse
12%
T-Helper Cell
12%
Overall Survival
12%
Tumor-Infiltrating Lymphocytes
12%
Homeostasis
12%
Immune Response
12%
Cell Killing
8%
Cell Adhesion
8%
Clonal Evolution
8%
Keyphrases
Chemotherapy
50%
Macrophages
50%
Polyclonal Metastasis
50%
B Cell Infiltration
50%
Triple-negative Breast Cancer
50%
Tumor-associated Macrophages
50%
T Cells
50%
Cell-to-cell
50%
T Helper Cells
25%
Pharmacological Inhibitors
25%
Claudin-low Breast Cancer
25%
Treatment Response
25%
B Cells
25%
Claudin-low
25%
CSF1R
25%
Overall Survival
12%
Differential Treatment
12%
Treatment Regimen
12%
Tertiary Lymphoid Structures
12%
Immune Response
12%
Tumor Immune Microenvironment
12%
Murine Tumors
12%
Cyclophosphamide
12%
High-dimensional Imaging
12%
Breast Cancer Model
12%
CD86
12%
Combination Immunotherapy
12%
CD4 T Cells
12%
Lung Metastasis
12%
Spatial Localization
12%
Antigen-presenting
12%
Cytolytic T Cells
12%
Tumor Microenvironment
12%
Lineage Depletion
12%
Murine Mammary Tumors
12%
Anti-tumor Response
12%
B220
12%
CSF1R Inhibitor
12%
Small Molecules
12%
Mesenchymal Subtype
12%
Single-cell RNA Sequencing (scRNA-seq)
12%
Immunomodulatory Effect
12%
Metabolic Heterogeneity
12%
Null Mice
12%
Mouse Model
12%
Low-dose Cyclophosphamide
12%
Syngeneic
12%
Activated B Cells
12%
Tumor Metastasis
12%
Combination Therapy
12%
